Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2006 1
2007 1
2009 1
2010 1
2011 3
2012 3
2013 3
2016 3
2017 2
2018 1
2019 1
2020 1
2021 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
ZBP1 activation triggers hematopoietic stem and progenitor cell death resulting in bone marrow failure in mice.
Roderick-Richardson JE, Lim SE, Suzuki S, Ahmad MH, Selway J, Suleiman R, Karna K, Lehman J, O'Donnell J, Castilla LH, Maelfait J, Rehwinkel J, Kelliher MA. Roderick-Richardson JE, et al. Among authors: suzuki s. Proc Natl Acad Sci U S A. 2024 Jan 23;121(4):e2309628121. doi: 10.1073/pnas.2309628121. Epub 2024 Jan 16. Proc Natl Acad Sci U S A. 2024. PMID: 38227660
The 10th Japan Bioanalysis Forum Symposium conference: a report.
Sano Y, Ohtsu Y, Igarashi H, Hosogi J, Komaba J, Mabuchi M, Yamaguchi T, Kamimori H, Arakawa T, Nakamura T, Nakai K, Hara H, Kakehi M, Suzuki S, Uchiyama H, Kawai Y, Nagao A, Nishiguchi Y. Sano Y, et al. Among authors: suzuki s. Bioanalysis. 2019 Jul;11(14):1303-1308. doi: 10.4155/bio-2019-0174. Epub 2019 Aug 8. Bioanalysis. 2019. PMID: 31392898 Free article.
Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial.
Matsuyama N, Shimizu S, Ueda K, Suzuki T, Suzuki S, Miura R, Katayama A, Ando M, Mizuno M, Hirakawa A, Hayakawa M, Sato Y. Matsuyama N, et al. Among authors: suzuki s. BMJ Open. 2022 Apr 26;12(4):e057073. doi: 10.1136/bmjopen-2021-057073. BMJ Open. 2022. PMID: 35473726 Free PMC article. Clinical Trial.
Hemangiopericytoma in the lateral ventricle.
Suzuki S, Wanifuchi H, Shimizu T, Kubo O. Suzuki S, et al. Neurol Med Chir (Tokyo). 2009 Nov;49(11):520-3. doi: 10.2176/nmc.49.520. Neurol Med Chir (Tokyo). 2009. PMID: 19940401 Free article.
Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions.
Patel SA, Cerny J, Gerber WK, Ramanathan M, Ediriwickrema A, Tanenbaum B, Hutchinson L, Meng X, Flahive J, Barton B, Gillis-Smith AJ, Suzuki S, Khedr S, Selove W, Higgins AW, Miron PM, Simin K, Woda B, Gerber JM. Patel SA, et al. Among authors: suzuki s. EJHaem. 2023 Sep 11;4(4):1059-1070. doi: 10.1002/jha2.791. eCollection 2023 Nov. EJHaem. 2023. PMID: 38024632 Free PMC article.
23 results